Posted June 10, 2021
Big Pharma has been trying to create a blockbuster drug for the very lucrative Alzheimer’s Disease market for more than a decade. But they have repeatedly failed, mainly because they start with the wrong presuppositions on the cause of Alzheimer’s, basing it on “genetics” instead of environmental causes. Read more.